Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil, a topical solution, was found to slow balding in most cases and increase hair density in some, but only a few saw significant cosmetic improvement.

People with early onset hair loss (Androgenetic Alopecia) in Ile-Ife, Nigeria, have significantly lower iron levels compared to those with adult-onset hair loss.

Mesotherapy is more effective and preferred for female hair loss than topical minoxidil.

Excision with primary closure is an excellent treatment for extensive acne keloidalis nuchae.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Proper skin care and dermocosmetics improve skin issues in diabetes patients.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Higher lead and cadmium, and lower zinc and iron levels in the blood might be linked to chronic hair loss in women.

Some vitamins and minerals are important for preventing hair loss, but treating hair loss with them without a known deficiency is not proven effective.

Intermediate filaments are crucial for cell differentiation and stem cell function.

Some diets and supplements might help with skin disorders, but their effectiveness varies and more research is needed.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Both surgical and non-surgical hair loss treatments lack a standard treatment plan and sufficient patient satisfaction data.

Heavy metals might contribute to hair loss in Telogen Effluvium.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

The patient recovered well and returned to college without any lasting issues.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

Nutritional supplements can help manage hair loss and promote hair growth by strengthening hair roots and countering harmful effects of pollution, smoking, and deficiencies in vitamins and minerals.

Low iron levels are significantly linked to hair loss in women.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Combining minoxidil with microneedling or spironolactone is more effective for female hair loss than using minoxidil alone.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

The microneedle patch with quercetin, zinc, and copper effectively promotes hair regrowth for androgenic alopecia.